Literature DB >> 11594456

Mechanisms of signal transduction activated by sublytic assembly of terminal complement complexes on nucleated cells.

F Niculescu1, H Rus.   

Abstract

The sublytic assembly of C5b-7, C5b-8, and C5b-9, activates membrane phospholipases through heterotrimeric G proteins and stimulates a variety of cellular activities including prostanoids, leukotrienes, and cytokines synthesis. Activation of mitotic signaling through Ras, Raf-1, ERK1, and phosphatidylinositol-3 kinase (PI3-K) was induced in B lymphocytes, endothelial, and smooth muscle cells. PI3-K activation by C5b-9 induced STAT3 phosphorylation and translocation from cytoplasm to nucleus. This complex signaling mechanism is directly involved in many biological functions such as endo- and exocytosis, cell cycle progression, activation of transcription, and protein synthesis. The key role of this signaling pathway is reflected on cell survival and proliferation in acute and chronic inflammation where complement activation is an ubiquitous event.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11594456     DOI: 10.1385/ir:24:2:191

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   4.505


  63 in total

Review 1.  Cytokines and growth factors in atherogenesis.

Authors:  S K Clinton; P Libby
Journal:  Arch Pathol Lab Med       Date:  1992-12       Impact factor: 5.534

2.  Membrane vesiculation protects erythrocytes from destruction by complement.

Authors:  K Iida; M B Whitlow; V Nussenzweig
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

Review 3.  The implications of angiogenesis for the biology and therapy of cancer metastasis.

Authors:  I J Fidler; L M Ellis
Journal:  Cell       Date:  1994-10-21       Impact factor: 41.582

4.  Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination.

Authors:  D F Carney; T J Lang; M L Shin
Journal:  J Immunol       Date:  1990-07-15       Impact factor: 5.422

Review 5.  Immune mechanisms in atherogenesis.

Authors:  S Stemme; G K Hansson
Journal:  Ann Med       Date:  1994-06       Impact factor: 4.709

6.  Complement activation and atherosclerosis.

Authors:  F Niculescu; H Rus
Journal:  Mol Immunol       Date:  1999 Sep-Oct       Impact factor: 4.407

7.  Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation.

Authors:  B E Hawes; T van Biesen; W J Koch; L M Luttrell; R J Lefkowitz
Journal:  J Biol Chem       Date:  1995-07-21       Impact factor: 5.157

8.  Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase.

Authors:  F Niculescu; T Badea; H Rus
Journal:  Atherosclerosis       Date:  1999-01       Impact factor: 5.162

9.  Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for an obligate autocrine mechanism promoting cell proliferation induced by G-protein-coupled receptor agonist.

Authors:  C J Molloy; J E Pawlowski; D S Taylor; C E Turner; H Weber; M Peluso
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

10.  Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits.

Authors:  P S Seifert; F Hugo; G K Hansson; S Bhakdi
Journal:  Lab Invest       Date:  1989-06       Impact factor: 5.662

View more
  23 in total

1.  The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Talat H Malik; Andrea Cortini; Daniele Carassiti; Joseph J Boyle; Dorian O Haskard; Marina Botto
Journal:  Circulation       Date:  2010-10-25       Impact factor: 29.690

Review 2.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

3.  Complement factors C1q, C3 and C5b-9 in the posterior sclera of guinea pigs with negative lens-defocused myopia.

Authors:  Ting-Ting Gao; Qin Long; Xue Yang
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

4.  Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Vinay K Bhatia; Sheng Yun; Viola Leung; David C Grimsditch; G Martin Benson; Marina B Botto; Joseph J Boyle; Dorian O Haskard
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

5.  T cell activation by terminal complex of complement and immune complexes.

Authors:  Anil K Chauhan; Terry L Moore
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

Review 6.  Complement and periodontitis.

Authors:  George Hajishengallis
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

Review 7.  Role of complement and complement regulatory proteins in the complications of diabetes.

Authors:  Pamela Ghosh; Rupam Sahoo; Anand Vaidya; Michael Chorev; Jose A Halperin
Journal:  Endocr Rev       Date:  2015-04-10       Impact factor: 19.871

Review 8.  Redox signaling and the innate immune system in alcoholic liver disease.

Authors:  Jessica I Cohen; Xiaocong Chen; Laura E Nagy
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

Review 9.  Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer.

Authors:  Sonia I Vlaicu; Cosmin A Tegla; Cornelia D Cudrici; Jacob Danoff; Hassan Madani; Adam Sugarman; Florin Niculescu; Petru A Mircea; Violeta Rus; Horea Rus
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

Review 10.  Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival.

Authors:  Cosmin A Tegla; Cornelia Cudrici; Violeta Rus; Takahiro Ito; Sonia Vlaicu; Anil Singh; Horea Rus
Journal:  J Neuroimmunol       Date:  2009-07-04       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.